Evolent Health Inc (EVH) Stock AnalysisEVHEvolent Health Inc

Evolent Health, Inc. is a health care company connecting care for people with complex conditions like cancer, cardiovascular disease, and musculoskeletal diagnoses. The Company offers primary solutions, including specialty care management services and administrative services. It provides comprehensive quality management for oncology and cardiology patients from diagnosis through advanced care planning services, as well as identifying quality, lowest cost of care for outpatient orthopedic surgeries. Its administrative services solution includes an integrated value-based care platform designed to help customers manage and administer patient health in a cost-effective manner. It operates in the Healthcare sector (SERVICES-MANAGEMENT SERVICES industry).

Evolent Health Inc is currently priced at $4.60, which is below the average analyst price target of $6. This suggests potential upside of approximately 30.43%. However, the stock has a forward P/E ratio of 25.91, indicating that it may be overvalued relative to its earnings potential. The recent RSI of 49.75 suggests the stock is neither overbought nor oversold, indicating a neutral momentum. The main risk is the high net debt-to-EBITDA ratio of 7x, which could pressure the company to raise capital under unfavorable conditions.

13 analysts cover EVH: 13 rate it Buy, 0 Hold and 0 Sell. The average price target is 9.33.